Make a complete assessment of a marketed product or pipeline compound across its full range of indications with our detailed analysis of over 2,000 drugs.
Our newly restructured Drug Analysis incorporates data from across both our company and disease portfolios to give you a complete perspective on a product, all in one place. Browse individual drug profiles to review pivotal clinical trial data for key pipeline agents, or see how marketed drugs are satisfying unmet needs and what challenges lie ahead. Want a broader view? Cutting-edge interactive Tableau dashboards allow you to compare clinical and commercial drug attributes side by side to better determine competitiveness in the marketplace.
At the end of the day, Datamonitor Healthcare is still the best on the market.
Product Manager, Merck
Review our expert analysis of pivotal clinical trial data for key insights into a product’s safety and efficacy. Our research will put you in the best position to evaluate a drug’s clinical profile against related treatments, with details of sample study sizes and durations, target patients, dosages tested, and result summaries.
Clinical and commercial attractiveness
Review a drug against a number of clinical and commercial parameters to understand its future potential. Our drug assessment summaries combine these measures to identify a drug’s overall positioning against its competitors, allowing you to compare both pipeline candidates and marketed drugs.
See our summaries of strengths, weaknesses, opportunities, and threats to quickly identify the most important issues facing a chosen product. You can assess the extent to which a drug is satisfying unmet needs in its indication, and where opportunities exist for product differentiation. Are side-effect profiles favorable? Are there new opportunities through combination therapy? What about biosimilar and generic competition? Datamonitor’s SWOT analyses allow you to answer all these questions and more at a glance.
Our extensive primary research surveys with key opinion leaders provide insights into the future uptake and application of treatments, while qualitative physician perceptions will help you to identify key selling points and perceived weaknesses of products on the market. Detailed analyses of treatment algorithms allow you to see drugs’ strategic positioning and whether developers are pursuing repositioning strategies.